Evaluation of a Clinical Score for Predicting Atrial Fibrillation in Cryptogenic Stroke Patients with Insertable Cardiac Monitors: Results from the CRYSTAL AF Study

Overview

Journal Ther Adv Neurol Disord

Specialty Neurology

Date 2019 Apr 23

PMID 31007721

Citations 8

Authors

Susan X Zhao

Paul D Ziegler

Michael H Crawford

Calvin Kwong

Jodi L Koehler

Rod S Passman

Affiliations

Soon will be listed here.

Abstract

Background: The HAVOC score was previously developed to predict the risk of atrial fibrillation (AF) after cryptogenic stroke (CS) or transient ischemic attack (TIA). The purpose of this study was to apply the HAVOC score to patients who received insertable cardiac monitors (ICMs) in the CRYSTAL AF study.

Methods: All patients from the CRYSTAL AF study who received an ICM were included. HAVOC score (one point each for peripheral vascular disease and obesity with body mass index >30, two points each for hypertension, age ⩾ 75, valvular heart disease, and coronary artery disease, 4 points for congestive heart failure) was computed for all patients. The primary endpoint was AF detection by 12 months of ICM monitoring.

Results: A total of 214 patients who received ICM were included. AF was detected in 40 patients while the remaining 174 patients were AF negative. The HAVOC score was significantly higher among patients with AF [median 3.0 with interquartile range (IQR) 2-4] than those without AF [median 2.0 (IQR 0-3)], = 0.01. AF increased significantly across the three HAVOC score groups: 11% in Group A (score 0-1), 18% in Group B (score 2-3), and 32 % in Group C (score ⩾ 4) with = 0.02.

Conclusions: The HAVOC score was shown in this post hoc analysis of CRYSTAL AF to successfully stratify AF risk post CS or TIA. The 11% AF rate in the lowest HAVOC score group highlights the significance of nontraditional contributors to AF and ischemic stroke.

Citing Articles

Left Ventricular Diastolic Dysfunction with Elevated Filling Pressures Is Associated with Embolic Stroke of Undetermined Source and Atrial Fibrillation.

Bashir Z, Shu L, Guo Y, Chen E, Wang S, Goldstein E Tomography. 2024; 10(10):1694-1705.

PMID: 39453041 PMC: 11511054. DOI: 10.3390/tomography10100124.

Risk scores for prediction of paroxysmal atrial fibrillation after acute ischemic stroke or transient ischemic attack: A systematic review and meta-analysis.

Kazemian S, Zarei D, Bozorgi A, Nazarian S, Issaiy M, Tavolinejad H Int J Cardiol Cardiovasc Risk Prev. 2024; 21:200249.

PMID: 38496328 PMC: 10940799. DOI: 10.1016/j.ijcrp.2024.200249.

Risk Stratification Tools to Guide a Personalized Approach for Cardiac Monitoring in Embolic Stroke of Undetermined Source.

Louka A, Nagraj S, Adamou A, Perlepe K, Godefroy O, Bugnicourt J J Am Heart Assoc. 2023; 12(18):e030479.

PMID: 37681521 PMC: 10547268. DOI: 10.1161/JAHA.123.030479.

Cryptogenic stroke as a working diagnosis: the need for an early and comprehensive diagnostic work-up.

Acampa M, Lazzerini P, Lattanzi S, Rubiera M BMC Neurol. 2023; 23(1):153.

PMID: 37060045 PMC: 10103391. DOI: 10.1186/s12883-023-03206-6.

ESC Working Group on e-Cardiology Position Paper: accuracy and reliability of electrocardiogram monitoring in the detection of atrial fibrillation in cryptogenic stroke patients: In collaboration with the Council on Stroke, the European Heart Rhythm....

Dilaveris P, Antoniou C, Caiani E, Casado-Arroyo R, Climent A, Cluitmans M Eur Heart J Digit Health. 2023; 3(3):341-358.

PMID: 36712155 PMC: 9707962. DOI: 10.1093/ehjdh/ztac026.

References

Mohr J, Thompson J, Lazar R, Levin B, Sacco R, Furie K . A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2002; 345(20):1444-51. DOI: 10.1056/NEJMoa011258. View

Stewart S, Hart C, Hole D, McMurray J . A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002; 113(5):359-64. DOI: 10.1016/s0002-9343(02)01236-6. View

Patton K, Zacks E, Chang J, Shea M, Ruskin J, MacRae C . Clinical subtypes of lone atrial fibrillation. Pacing Clin Electrophysiol. 2005; 28(7):630-8. DOI: 10.1111/j.1540-8159.2005.00161.x. View

Romero-Corral A, Montori V, Somers V, Korinek J, Thomas R, Allison T . Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006; 368(9536):666-78. DOI: 10.1016/S0140-6736(06)69251-9. View

Wolf P, Abbott R, Kannel W . Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991; 22(8):983-8. DOI: 10.1161/01.str.22.8.983. View

Suissa L, Bertora D, Lachaud S, Mahagne M . Score for the targeting of atrial fibrillation (STAF): a new approach to the detection of atrial fibrillation in the secondary prevention of ischemic stroke. Stroke. 2009; 40(8):2866-8. DOI: 10.1161/STROKEAHA.109.552679. View

Aizer A, Gaziano J, Cook N, Manson J, Buring J, Albert C . Relation of vigorous exercise to risk of atrial fibrillation. Am J Cardiol. 2009; 103(11):1572-7. PMC: 2687527. DOI: 10.1016/j.amjcard.2009.01.374. View

Krishnamoorthy S, Lip G, Lane D . Alcohol and illicit drug use as precipitants of atrial fibrillation in young adults: a case series and literature review. Am J Med. 2009; 122(9):851-856.e3. DOI: 10.1016/j.amjmed.2009.02.012. View

Sinha A, Diener H, Morillo C, Sanna T, Bernstein R, Di Lazzaro V . Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): design and rationale. Am Heart J. 2010; 160(1):36-41.e1. DOI: 10.1016/j.ahj.2010.03.032. View

10.

Malik S, Hicks W, Schultz L, Penstone P, Gardner J, Katramados A . Development of a scoring system for atrial fibrillation in acute stroke and transient ischemic attack patients: the LADS scoring system. J Neurol Sci. 2010; 301(1-2):27-30. DOI: 10.1016/j.jns.2010.11.011. View

11.

Healey J, Connolly S, Gold M, Israel C, Van Gelder I, Capucci A . Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012; 366(2):120-9. DOI: 10.1056/NEJMoa1105575. View

12.

Camm A, Corbucci G, Padeletti L . Usefulness of continuous electrocardiographic monitoring for atrial fibrillation. Am J Cardiol. 2012; 110(2):270-6. DOI: 10.1016/j.amjcard.2012.03.021. View

13.

Rienstra M, McManus D, Benjamin E . Novel risk factors for atrial fibrillation: useful for risk prediction and clinical decision making?. Circulation. 2012; 125(20):e941-6. PMC: 3725394. DOI: 10.1161/CIRCULATIONAHA.112.112920. View

14.

Camm A, Lip G, De Caterina R, Savelieva I, Atar D, Hohnloser S . 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012; 33(21):2719-47. DOI: 10.1093/eurheartj/ehs253. View

15.

Bugnicourt J, Flament M, Guillaumont M, Chillon J, Leclercq C, Canaple S . Predictors of newly diagnosed atrial fibrillation in cryptogenic stroke: a cohort study. Eur J Neurol. 2012; 20(10):1352-9. DOI: 10.1111/ene.12017. View

16.

Ritter M, Kochhauser S, Duning T, Reinke F, Pott C, Dechering D . Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors. Stroke. 2013; 44(5):1449-52. DOI: 10.1161/STROKEAHA.111.676189. View

17.

Hainer V, Aldhoon-Hainerova I . Obesity paradox does exist. Diabetes Care. 2013; 36 Suppl 2:S276-81. PMC: 3920805. DOI: 10.2337/dcS13-2023. View

18.

Rojo-Martinez E, Sandin-Fuentes M, Calleja-Sanz A, Cortijo-Garcia E, Garcia-Bermejo P, Ruiz-Pinero M . [High performance of an implantable Holter monitor in the detection of concealed paroxysmal atrial fibrillation in patients with cryptogenic stroke and a suspected embolic mechanism]. Rev Neurol. 2013; 57(6):251-7. View

19.

Christensen L, Krieger D, Hojberg S, Pedersen O, Karlsen F, Jacobsen M . Paroxysmal atrial fibrillation occurs often in cryptogenic ischaemic stroke. Final results from the SURPRISE study. Eur J Neurol. 2014; 21(6):884-9. DOI: 10.1111/ene.12400. View

20.

Kernan W, Ovbiagele B, Black H, Bravata D, Chimowitz M, Ezekowitz M . Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014; 45(7):2160-236. DOI: 10.1161/STR.0000000000000024. View